Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Oct 15, 2007 (Vol. 27, No. 18)

Kramer's REMARKable WebSite

URL:www.mansfield.ohio-state.edu/~dkramer
  • Useful links
  • Not well organized
An interesting site with an unusual opening page, Kramer’s REMARKable website is different things to different people. If you are a student at Ohio State University, the pages are headliners for botany classes offered by Dr. Kramer. If you’re a wanna-be botanist, the site’s links to outside botanical information are relevant and useful. If you’re a teacher, the site’s links, entitled Teacher’s Academy, are sure to please. Last, if you’re thinking about a career in botany, the link to the Botanical Society of America’s pages on the subject will surely be of interest. There are a few aspects of the site that need work. The opening page, complete with Dr. Kramer’s phone number is unusual, but also not a very efficient use of space. Also the site’s Index page is kind of higgledy-piggledy in its layout. It wouldn’t take much to tidy this up and improve the appearance of the offerings considerably. Here’s hoping it happens.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »